AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.13) per share. This is a 62.5 percent decrease over losses of $(0.08) per share from the same period last year.
Aerovate Therapeutics: Q2 Earnings Insights
Aerovate Therapeutics (NASDAQ:AVTE) reported its Q2 earnings results on Monday, August 15, 2022 at 09:00 AM.
Here's what investors need to know about the announcement.